Delays Harmless for Most Macular Degeneration Patients Richard Mark Kirkner

https://www.medscape.com/viewarticle/delays-harmless-most-macular-degeneration-patients-2026a1000on1 Short prior authorization delays for drug therapy did not cause vision loss in most patients newly diagnosed with age-related macular degeneration (AMD). However, a small number of people — especially those with subretinal hemorrhage — experienced loss of visual acuity while waiting and failed to recover after 6 months.